Thermostabilized chondroitinase ABC Promotes Neuroprotection after Contusion Spinal Cord Injury

Document Type : Original Article


1 Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran

2 Professor, Stem Cells Research Center, Kerman University of Medical Sciences, Kerman, Iran

3 Assistant Professor, Stem Cells Research Center, Kerman University of Medical Sciences, Kerman, Iran

4 Assistant Professor, Department of Clinical Biochemistry, Faculty of Medicine, Kerman University of Medical Sciences, Kerman, Iran


Background: Chondroitinase ABC (cABC), due to its loosening impact on the extracellular matrix scaffold, has been used to enhance regeneration of injured axonal tracts after spinal cord injury (SCI). However, cABC thermal instability at physiological temperature has limited its clinical application. The disaccharide trehalose has been shown to increase the stability of cABC in body temperature. Therefore, the present study was conducted to assess the effect of combined trehalose and cABC on inflammation, lipid peroxidation and histopathological changes following SCI.
Methods: Male Wistar rats were randomized into six groups (n=12) including sham, SCI, vehicle, trehalose, cABC and trehalose + cABC. In sham group, only laminectomy was performed. Other groups underwent laminectomy followed by contusion spinal cord injury. Twenty four hours after treatment, the level of IL-1β, Myeloperoxidase (MPO) and Malondialdehyde (MDA) were measured. Histopathological changes were also scored.
Results: Spinal cord injury in rats resulted in severe trauma characterized by increase in inflammation, oxidative stress, neutrophils infiltration, hemorrhage, necrosis and edema. The levels of IL-1β, MDA and MPO were 260.3±16.4 nmol/mg protein, 1.2±0.06 mU/mg protein and 18.9±0.7 pg/mg protein, respectively in the vehicle group. However, combined treatment with cABC and trehalose reduced the amount of these factors significantly to 142.4±17 nmol/mg protein, 0.57±0.03 mU/mg protein and 13.8±0.4 pg/mg protein, respectively (p <0.05). In addition, treatment with cABC and trehalose improved histopathological alterations.
Conclusions: The present data suggest that coadministration of trehalose and cABC exhibits neuroprotection effect through reducing inflammation and tissue injury events associated with SCI.



  1. Ahuja CS, Wilson JR, Nori S, Kotter MR, Druschel C, Curt A, et al. Traumatic spinal cord injury. Nat Rev Dis Primers 2017; 3:17018.
  2. Putatunda R, Bethea JR, Hu WH. Potential immunotherapies for traumatic brain and spinal cord injury. Chinese Journal of Traumatology 2018; 21(3):125-36.
  3. Gensel JC, Zhang B. Macrophage activation and its role in repair and pathology after spinal cord injury. Brain Res 2015; 1619:1-11.
  4. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008; 209(2):294-301.
  5. Holmberg E, Zhang SX, Sarmiere PD, Kluge BR, White JT, Doolen S. Statins decrease chondroitin sulfate proteoglycan expression and acute astrocyte activation in central nervous system injury. Exp Neurol 2008; 214(1):78-86.
  6. Huang WC, Kuo WC, Cherng JH, Hsu SH, Chen PR, Huang SH, et al. Chondroitinase ABC promotes axonal re-growth and behavior recovery in spinal cord injury. Biochem Bioph Res Co 2006; 349(3):963-8.
  7. Kanno H, Pressman Y, Moody A, Berg R, Muir EM, Rogers JH, et al. Combination of engineered Schwann cell grafts to secrete neurotrophin and chondroitinase promotes axonal regeneration and locomotion after spinal cord injury. J Neurosci 2014; 34(5):1838-55.
  8. Lee H, McKeon RJ, Bellamkonda RV. Sustained delivery of thermostabilized chABC enhances axonal sprouting and functional recovery after spinal cord injury. Proc Natl Acad Sci USA 2010; 107(8):3340-5.
  9. Nazari-Robati M, Khajeh K, Aminian M, Fathi-Roudsari M, Golestani A. Co-solvent mediated thermal stabilization of chondroitinase ABC I form Proteus vulgaris. Int J Biol Macromol 2012; 50(3):487-92.
  10. Richards AB, Krakowka S, Dexter LB, Schmid H, Wolterbeek AP, Waalkens-Berendsen DH, et al. Trehalose: a review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol 2002; 40(7):871-98.
  11. Jain NK, Roy I. Effect of trehalose on protein structure. Protein Sci 2009; 18(1):24-36.
  12. Echigo R, Shimohata N, Karatsu K, Yano F, Kayasuga-Kariya Y, Fujisawa A, et al. Trehalose treatment suppresses inflammation, oxidative stress, and vasospasm induced by experimental subarachnoid hemorrhage. J Transl Med 2012; 10:80.
  13. Cejka C, Kossl J, Hermankova B, Holan V, Kubinova S, Olmiere C, et al. The healing of oxidative injuries with trehalose in UVB-Irradiated rabbit corneas. Oxid Med Cell Longev 2019; 2019:1-10.
  14. Nasouti R, Khaksari M, Mirzaee M, Nazari-Robati M. Trehalose protects against spinal cord injury through regulating heat shock proteins 27 and 70 and caspase-3 genes expression. J Basic Clin Physiol Pharmacol 2019; 31(1):1-8.
  15. Barritt AW, Davies M, Marchand F, Hartley R, Grist J, Yip P, et al. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci 2006; 26(42):10856-67.
  16. Zhang D, Ma G, Hou M, Zhang T, Chen L, Zhao C. The neuroprotective effect of puerarin in acute spinal cord injury rats. Cell Physiol Biochem 2016; 39(3):1152-64.
  17. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Inv Dermatol 1982; 78(3):206-9.
  18. Esterbauer H, Cheeseman KH. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Method Enzymol 1990; 186:407-21.
  19. Kahveci R, Gokce EC, Gurer B, Gokce A, Kisa U, Cemil DB, et al. Neuroprotective effects of rosuvastatin against traumatic spinal cord injury in rats. Eur J Pharmacol 2014; 741:45-54.
  20. Ahmed A, Patil AA, Agrawal DK. Immunobiology of spinal cord injuries and potential therapeutic approaches. Mol Cell Biochem 2018; 441(1-2):181-9.
  21. Bao F, Chen Y, Dekaban GA, Weaver LC. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats. J Neurochem 2004; 88(6):1335-44.
  22. Cheng CH, Lin CT, Lee MJ, Tsai MJ, Huang WH, Huang MC, et al. Local delivery of high-dose chondroitinase abc in the sub-acute stage promotes axonal outgrowth and functional recovery after complete spinal cord transection. PloS one 2015; 10(9):e0138705.
  23. Bartus K, James ND, Bosch KD, Bradbury EJ. Chondroitin sulphate proteoglycans: key modulators of spinal cord and brain plasticity. Exp Neurol 2012; 235(1):5-17.
  24. Burke SJ, Lu D, Sparer TE, Karlstad MD, Collier JJ. Transcription of the gene encoding TNF-alpha is increased by IL-1beta in rat and human islets and beta-cell lines. Mol Immunol 2014; 62(1):54-62.
  25. Boato F, Rosenberger K, Nelissen S, Geboes L, Peters EM, Nitsch R, et al. Absence of IL-1beta positively affects neurological outcome, lesion development and axonal plasticity after spinal cord injury. J Neuroinflammation 2013; 10:6.
  26. Neirinckx V, Coste C, Franzen R, Gothot A, Rogister B, Wislet S. Neutrophil contribution to spinal cord injury and repair. J Neuroinflammation 2014; 11:150.
  27. Lee SM, Rosen S, Weinstein P, van Rooijen N, Noble-Haeusslein LJ. Prevention of both neutrophil and monocyte recruitment promotes recovery after spinal cord injury. J Neurotrauma 2011; 28(9):1893-907.
  28. Hall ED, Wang JA, Bosken JM, Singh IN. Lipid peroxidation in brain or spinal cord mitochondria after injury. J Bioenerg Biomembr 2016; 48(2):169-74.
  29. Nazari Robati M, Norouzi A, Nasouti R. Effect of Trehalose on the Expression of Heat Shock Protein 70 Gene in PC12 Cells Treated with Hydrogen Peroxide. J Mazandaran Univ Med Sci 2019; 29(172):1-9. [In Persian].
  30. Taya K, Hirose K, Hamada S. Trehalose inhibits inflammatory cytokine production by protecting IkappaB-alpha reduction in mouse peritoneal macrophages. Arch Oral Biol 2009; 54(8):749-56.